Researchers analyzed serum peptide profiles in pregnant women to identify peptide biomarkers that could distinguish preeclampsia cases from normal pregnancies, utilizing peptidomic techniques to characterize protein fragments circulating in blood samples. The study identified specific peptide signatures, including TB4-Fragment, that showed potential diagnostic value for preeclampsia detection. This evidence comes from human clinical studies analyzing biomarker patterns in patient serum samples.